Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Cash Flow Quality Index
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow Quality Index of 1.56x as of June 2025. Operating cash flow of CN¥174.53 Million exceeds net income of CN¥112.08 Million, indicating high earnings quality where cash backs reported profits. Explore Zhejiang Huahai Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Huahai Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year earnings quality comparison for Zhejiang Huahai Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Zhejiang Huahai Pharmaceutical Co Ltd (600521) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.62x | CN¥1.23 Billion | CN¥266.40 Million | ▲ +135.4% |
| 2024 | 1.96x | CN¥2.17 Billion | CN¥1.11 Billion | ▼ -26.5% |
| 2023 | 2.67x | CN¥2.22 Billion | CN¥830.47 Million | ▲ +152.6% |
| 2022 | 1.06x | CN¥1.24 Billion | CN¥1.18 Billion | ▼ -45.9% |
| 2021 | 1.95x | CN¥938.43 Million | CN¥480.64 Million | ▲ +24.8% |
| 2020 | 1.56x | CN¥1.56 Billion | CN¥994.60 Million | ▼ -45.9% |
| 2019 | 2.89x | CN¥1.75 Billion | CN¥606.83 Million | ▲ +474.3% |
| 2018 | 0.50x | CN¥67.90 Million | CN¥134.90 Million | ▼ -42.5% |
| 2017 | 0.88x | CN¥546.24 Million | CN¥623.59 Million | ▼ -7.6% |
| 2016 | 0.95x | CN¥433.10 Million | CN¥456.90 Million | ▲ +112.0% |
| 2015 | 0.45x | CN¥195.31 Million | CN¥436.72 Million | ▼ -65.1% |
| 2014 | 1.28x | CN¥328.61 Million | CN¥256.73 Million | ▼ -5.1% |
| 2013 | 1.35x | CN¥490.29 Million | CN¥363.42 Million | ▲ +87.3% |
| 2012 | 0.72x | CN¥243.83 Million | CN¥338.49 Million | ▼ -21.9% |
| 2011 | 0.92x | CN¥197.51 Million | CN¥214.09 Million | ▼ -71.2% |
| 2010 | 3.20x | CN¥299.47 Million | CN¥93.53 Million | ▲ +65.8% |
| 2009 | 1.93x | CN¥317.44 Million | CN¥164.39 Million | ▲ +243.7% |
| 2008 | 0.56x | CN¥84.20 Million | CN¥149.86 Million | ▼ -45.7% |
| 2007 | 1.03x | CN¥136.52 Million | CN¥132.05 Million | ▲ +46.8% |
| 2006 | 0.70x | CN¥77.54 Million | CN¥110.07 Million | ▲ +70.5% |
| 2005 | 0.41x | CN¥53.30 Million | CN¥128.99 Million | ▼ -69.9% |
| 2004 | 1.37x | CN¥163.73 Million | CN¥119.13 Million | ▲ +129.9% |
| 2003 | 0.60x | CN¥47.41 Million | CN¥79.29 Million | ▼ -59.8% |
| 2002 | 1.49x | CN¥75.34 Million | CN¥50.61 Million | ▲ +69.6% |
| 2001 | 0.88x | CN¥37.51 Million | CN¥42.72 Million | — |